Financial Ratios | Aarti Drugs Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY16259.30  +417.00 (+2.63%)
SENSEX54318.47  +1344.63 (+2.54%)
  • top gainers
  • top losers
  • top volume
  • top value
  • indian indices
  • global indices

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE420.801.95 (+0.47 %)
PREV CLOSE (Rs.) 418.85
OPEN PRICE (Rs.) 428.00
BID PRICE (QTY) 420.00 (18)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4881
TODAY'S LOW / HIGH (Rs.)418.50 428.00
52 WK LOW / HIGH (Rs.)402.9 782.05
NSE419.650.55 (+0.13 %)
PREV CLOSE( Rs. ) 419.10
OPEN PRICE (Rs.) 420.85
BID PRICE (QTY) 419.65 (45)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 120786
TODAY'S LOW / HIGH(Rs.) 419.00 427.65
52 WK LOW / HIGH (Rs.)402.45 779.05

Financial Ratios

Select year
ParticularsMar2021Mar2020Mar2019Mar2018Mar2017
Operational & Financial Ratios
   Earnings Per Share (Rs)30.0960.6938.0634.9034.29
   CEPS(Rs)35.4420.4014.0312.9712.60
   DPS(Rs)2.502.001.001.001.00
   Book NAV/Share(Rs)98.01280.04230.45193.12167.72
   Tax Rate(%)24.0123.6931.5033.8929.49
Margin Ratios
   Core EBITDA Margin(%)20.4414.7013.5115.9914.79
   EBIT Margin(%)18.3412.3311.1812.9012.11
   Pre Tax Margin(%)17.1310.268.399.869.01
   PAT Margin (%)13.017.835.756.526.35
   Cash Profit Margin (%)15.3310.538.489.699.34
Performance Ratios
   ROA(%)16.789.336.316.387.13
   ROE(%)35.8123.6517.9719.2421.60
   ROCE(%)34.5221.3917.0117.3118.50
   Asset Turnover(x)1.291.191.100.981.12
   Sales/Fixed Asset(x)2.021.811.661.441.64
   Working Capital/Sales(x)4.676.438.0710.9616.70
Efficiency Ratios
   Fixed Capital/Sales(x)0.500.550.600.700.61
   Receivable days88.4195.7197.4597.1089.05
   Inventory Days62.7157.8061.3670.5254.97
   Payable days95.2792.6390.28112.7393.62
Valuation Parameters
   PER(x)23.092.0816.8314.5216.79
   PCE(x)19.616.2011.419.7611.42
   Price/Book(x)7.091.812.782.623.43
   Yield(%)0.360.400.160.200.17
   EV/Net Sales(x)3.160.861.291.401.55
   EV/Core EBITDA(x)15.315.819.438.569.50
   EV/EBIT(x)17.236.9611.5310.6611.85
   EV/CE(x)3.860.981.381.251.55
   M Cap / Sales3.010.650.970.961.15
Growth Ratio
   Net Sales Growth(%)19.3115.7125.524.054.85
   Core EBITDA Growth(%)66.6325.165.134.338.16
   EBIT Growth(%)77.4727.617.174.388.89
   PAT Growth(%)98.3057.549.050.6219.03
   EPS Growth(%)-50.4259.459.051.7920.82
Financial Stability Ratios
   Total Debt/Equity(x)0.380.580.931.201.20
   Current Ratio(x)1.781.451.331.191.16
   Quick Ratio(x)1.080.930.910.740.73
   Interest Cover(x)15.075.954.014.253.90
   Total Debt/Mcap(x)0.050.320.340.460.35